Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.
Characterizing the distribution of alterations in mesothelioma and their correlation to morphology.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Characterizing the distribution of alterations in mesothelioma and their correlation to morphology.
Characterizing the distribution of alterations in mesothelioma and their correlation to morphology. Am J Clin Pathol. 2023 09 01; 160(3):238-246.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Female
Humans
Immunohistochemistry
Lung Neoplasms
Male
Mesothelioma
Middle Aged
Pleural Neoplasms
Sarcoma
Tumor Suppressor Proteins
Ubiquitin Thiolesterase
authors with profiles
Melissa Tjota
Hedy Kindler